These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

939 related articles for article (PubMed ID: 33580518)

  • 1. Three salvianolic acids inhibit 2019-nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2.
    Hu S; Wang J; Zhang Y; Bai H; Wang C; Wang N; He L
    J Med Virol; 2021 May; 93(5):3143-3151. PubMed ID: 33580518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.
    Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2.
    Zhang Y; Hu S; Wang J; Xue Z; Wang C; Wang N
    Virology; 2021 Feb; 554():83-88. PubMed ID: 33387788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repositioning of histamine H
    Ge S; Wang X; Hou Y; Lv Y; Wang C; He H
    Eur J Pharmacol; 2021 Apr; 896():173897. PubMed ID: 33497607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
    Yang Q; Hughes TA; Kelkar A; Yu X; Cheng K; Park S; Huang WC; Lovell JF; Neelamegham S
    Elife; 2020 Oct; 9():. PubMed ID: 33103998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents.
    Mei J; Zhou Y; Yang X; Zhang F; Liu X; Yu B
    J Ethnopharmacol; 2021 Oct; 278():114303. PubMed ID: 34102269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
    Nayak SK
    Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosensor-based active ingredient recognition system for screening potential small molecular Severe acute respiratory syndrome coronavirus 2 entry blockers targeting the spike protein from Rugosa rose.
    Yu W; Yi SZ; Jiang CY; Guan JW; Xue R; Zhang XX; Zeng T; Tang H; Chen W; Han B
    Biomed Chromatogr; 2024 Oct; 38(10):e5987. PubMed ID: 39126351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) binding to angiotensin-converting enzyme 2.
    Zhu J; Yan H; Shi M; Zhang M; Lu J; Wang J; Chen L; Wang Y; Li L; Miao L; Zhang H
    Phytother Res; 2023 Aug; 37(8):3508-3521. PubMed ID: 37166054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening and evaluation of anti-SARS-CoV-2 components from Ephedra sinica by ACE2/CMC-HPLC-IT-TOF-MS approach.
    Lv Y; Wang S; Liang P; Wang Y; Zhang X; Jia Q; Fu J; Han S; He L
    Anal Bioanal Chem; 2021 May; 413(11):2995-3004. PubMed ID: 33608752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus.
    Wang N; Han S; Liu R; Meng L; He H; Zhang Y; Wang C; Lv Y; Wang J; Li X; Ding Y; Fu J; Hou Y; Lu W; Ma W; Zhan Y; Dai B; Zhang J; Pan X; Hu S; Gao J; Jia Q; Zhang L; Ge S; Wang S; Liang P; Hu T; Lu J; Wang X; Zhou H; Ta W; Wang Y; Lu S; He L
    Phytomedicine; 2020 Dec; 79():153333. PubMed ID: 32920291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Withanone from
    Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
    Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tinocordiside from
    Balkrishna A; Pokhrel S; Varshney A
    Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential antiviral activity of isorhamnetin against SARS-CoV-2 spike pseudotyped virus in vitro.
    Zhan Y; Ta W; Tang W; Hua R; Wang J; Wang C; Lu W
    Drug Dev Res; 2021 Dec; 82(8):1124-1130. PubMed ID: 33847382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and simulation analysis of hotspot residues interactions of SARS-CoV 2 with human ACE2 receptor.
    Veeramachaneni GK; Thunuguntla VBSC; Bobbillapati J; Bondili JS
    J Biomol Struct Dyn; 2021 Jul; 39(11):4015-4025. PubMed ID: 32448098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Salvianolic acid B and its magnesium salt inhibit SARS-CoV-2 infection of Vero-E6 cells by blocking spike protein-mediated membrane fusion].
    Yang C; Cheng C; Wang J; Chen K; Zhan J; Pan X; Xu X; Xu W; Liu S
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Apr; 41(4):475-482. PubMed ID: 33963705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Natural Bioactive Peptide from
    Wang Y; Wang Q; Chen X; Li B; Zhang Z; Yao L; Liu X; Zhang R
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corilagin and 1,3,6-Tri-
    Binette V; Côté S; Haddad M; Nguyen PT; Bélanger S; Bourgault S; Ramassamy C; Gaudreault R; Mousseau N
    Phys Chem Chem Phys; 2021 Jul; 23(27):14873-14888. PubMed ID: 34223589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astemizole as a drug to inhibit the effect of SARS-COV-2 in vitro.
    Wang X; Lu J; Ge S; Hou Y; Hu T; Lv Y; Wang C; He H
    Microb Pathog; 2021 Jul; 156():104929. PubMed ID: 33932547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anti-SARS-CoV-2 activity of amino acid modified cephalotaxine derivatives.
    Si M; An M; Xia Z; Mo X; Lu J; He H; Wang C
    Chem Biol Drug Des; 2024 Jun; 103(6):e14566. PubMed ID: 38858134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.